CROSS SYNC Inc. is pleased to announce that it has raised approximately 150 million yen in total through a third-party allotment of new shares, underwritten by Fukuda Denshi Co., Ltd., a manufacturer of medical equipment, and IT-Farm Inc. , an independent venture capital firm.
The funds raised will be invested in the following:
Accelerating the nationwide introduction of iBSEN DX for remote ICU use, which will be covered by insurance in June 2024
– Development to further expand the functionality of iBSEN DX, which received medical device certification in March 2024.
・Research and development of AI functions to be implemented next year
・Expanding iBSEN DX into new business areas, including overseas expansion
Also Read: Orizuru and Peptigrowth Develop Growth Factor Peptides
In order to promote the above, we will strengthen our organizational management structure through proactive recruitment activities.
SOURCE: PRTimes
